This time Dr. Samuel Waksal — who advised Stewart to sell all of her ImClone shares when he learned his firm's cancer drug wouldn't attain FDA approval — is being sued for $4 million by a former associate, according to the New York Post.
A former business associate, Kevin Glodek, charges that Waksal used him to raise capital for the new firm, then cut him out of millions of dollars in promised commissions, according to the civil suit filed Friday in Manhattan Supreme Court.
Glodek, 37, claims he’s owed the $4 million fee from a $40 million transaction in 2012 between Waksal and two investors based on a written agreement.
Before serving five years in prison for the insider trading scandal, Waksal was a titan of the biotech industry and a popular New York socialite. He even dated Stewart's daughter for nearly four years.
His fall was as epic as his rise.
More From Business Insider
- Kim Kardashian's Baby Could Have One Of These Names
- CANADA IS DOOMED: Three Signs The Country Up North Is Screwed Beyond All Recognition
- SNOWDEN: The Truth Is Coming, And The Government Can't Stop It By Murdering Me
- Martha Stewart